BPBT
HQL

Boston Private Bank & Trust’s abrdn Life Sciences Investors HQL Stock Holding History

Boston Private Bank & Trust’s Portfolio HQL Stock Details HQL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		$5K Hold
183
– – ﹤0.01% 896
2014
Q4 		$5K Hold
183
– – ﹤0.01% 964
2014
Q3 		$4K Hold
183
– – ﹤0.01% 965
2014
Q2 		$4K Hold
183
– – ﹤0.01% 908
2014
Q1 		$4K Hold
183
– – ﹤0.01% 934
2013
Q4 		$4K Hold
183
– – ﹤0.01% 946
2013
Q3 		$4K Buy
183
+3
+2% +$57 ﹤0.01% 888
2013
Q2 		$3K Buy
+180
New +$3.25K ﹤0.01% 882

Other funds holding HQL

NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
DA
Doliver Advisors Houston, Texas $442M AUM 34.09% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
OC
Oppenheimer & Co New York $9.37B AUM 36.4% 1-Year Est. Return
AIG
American International Group New York $609M AUM 23.67% 1-Year Est. Return

Boston Private Bank & Trust's HQL Position: Q1 2015 in Review

Boston Private Bank & Trust held its abrdn Life Sciences Investors (HQL) position steady in Q1 2015 at 183 shares worth $5K. The position accounts for ﹤0.01% of the portfolio, ranked #896.

Boston Private Bank & Trust first reported a position in HQL in Q2 2013 and has held it in 8 quarters since. 45 funds tracked by Wall St. Rank hold HQL as of Q1 2015.

  • Boston Private Bank & Trust held 183 shares of abrdn Life Sciences Investors worth $5K as of Q1 2015.
  • Boston Private Bank & Trust left its abrdn Life Sciences Investors share count unchanged in Q1 2015.
  • abrdn Life Sciences Investors made up ﹤0.01% of Boston Private Bank & Trust's portfolio in Q1 2015, its #896 holding.
  • Boston Private Bank & Trust first reported a position in abrdn Life Sciences Investors in Q2 2013 and has held it in 8 quarters since.
  • 45 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q1 2015.

Based on Boston Private Bank & Trust's 13F filing for Q1 2015, filed 9 Apr 2015.